2014
DOI: 10.1186/s13041-014-0081-y
|View full text |Cite
|
Sign up to set email alerts
|

Lack of evidence of the interaction of the Aβ peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's disease

Abstract: BackgroundAlzheimer’s disease (AD) is the leading form of dementia worldwide. The Aβ-peptide is believed to be the major pathogenic compound of the disease. Since several years it is hypothesized that Aβ impacts the Wnt signaling cascade and therefore activation of this signaling pathway is proposed to rescue the neurotoxic effect of Aβ.FindingsExpression of the human Aβ42 in the Drosophila nervous system leads to a drastically shortened life span. We found that the action of Aβ42 specifically in the glutamate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 25 publications
(37 reference statements)
0
6
0
Order By: Relevance
“…Consistently, GSK3-β inhibition can restore some of the Aβ toxic effects, similar to lithium or Congo-Red treatments (Crowther et al, 2004;Sofola-Adesakin et al, 2014;Sofola et al, 2010). By contrast, other reports found no restoration when GSK3-β was down-regulated in Aβ expressing neurons, claiming no Wnt-Aβ interaction in Drosophila AD models (Lüchtenborg and Katanaev, 2014). PI3K inhibition by downregulation of p65 regulatory subunit has also been used in Aβ, showing prevention of Aβ-induced neuronal electrophysiological defects (Chiang et al, 2010).…”
Section: Introductionmentioning
confidence: 76%
“…Consistently, GSK3-β inhibition can restore some of the Aβ toxic effects, similar to lithium or Congo-Red treatments (Crowther et al, 2004;Sofola-Adesakin et al, 2014;Sofola et al, 2010). By contrast, other reports found no restoration when GSK3-β was down-regulated in Aβ expressing neurons, claiming no Wnt-Aβ interaction in Drosophila AD models (Lüchtenborg and Katanaev, 2014). PI3K inhibition by downregulation of p65 regulatory subunit has also been used in Aβ, showing prevention of Aβ-induced neuronal electrophysiological defects (Chiang et al, 2010).…”
Section: Introductionmentioning
confidence: 76%
“…Consistently, GSK3-β inhibition can restore some of the Aβ toxic effects, similar to lithium or Congo red treatments (Crowther et al, 2004;Sofola et al, 2010;Sofola-Adesakin et al, 2014). By contrast, other reports found no restoration when GSK3-β was down-regulated in Aβ-expressing neurons, claiming no Wnt-Aβ interaction in Drosophila AD models (Lüchtenborg and Katanaev, 2014). PI3K inhibition by down-regulation of the p65 regulatory subunit has also been used in Aβ experiments, showing prevention of Aβ-induced neuronal electrophysiological defects (Chiang et al, 2010).…”
Section: Introductionmentioning
confidence: 77%
“…The following primary antibodies were used: mouse monoclonal antibody against bovine Gαo (1:20 dilution, Santa Cruz Biotechnology, sc-13532) and rabbit anti-dGao (1:50; (Luchtenborg et al, 2014)).…”
Section: Immunochemistry and Microscopymentioning
confidence: 99%
“…Animal models have the instrumental role in deciphering the disease mechanisms and in identifying / validating the treatment routes. Drosophila has been used to model a variety of human maladies, especially neurological ones (Bellen et al, 2019;Bolus et al, 2020;Katanaev et al, 2020;Katanaev and Kryuchkov, 2011;Luchtenborg and Katanaev, 2014). As the first step towards modelling GNAO1 paediatric encephalopathies in the fruit fly, we here describe humanization of the Drosophila Gαo locus, finding the human protein fully replaces the insect one's functions without any aberrations.…”
Section: Introductionmentioning
confidence: 96%
See 1 more Smart Citation